Share chart Achilles Therapeutics plc
Extended chart
Simple chart
About Achilles Therapeutics plc
Achilles Therapeutics Plc, биофармацевтическая компания, занимающаяся иммуноонкологической клинической стадией, разрабатывает прецизионные Т-клеточные терапии для лечения различных типов солидных опухолей. К числу основных кандидатов в продукты компании относятся CHIRON, который проходит фазу I / IIa клинических испытаний для использования в лечении распространенного немелкоклеточного рака легкого; и THETIS, продукт-кандидат в клинических испытаниях фазы I / IIa для использования при лечении метастатической или рецидивирующей меланомы. more details| IPO date | 2021-03-31 |
|---|---|
| ISIN | US00449L1026 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.achillestx.com |
| Цена ао | 1.48 |
| Change price per day: | 0% (1.48) |
|---|---|
| Change price per week: | 0% (1.48) |
| Change price per month: | 0% (1.48) |
| Change price per 3 month: | +28.14% (1.155) |
| Change price per half year: | +49.49% (0.99) |
| Change price per year: | +94.74% (0.76) |
| Change price per 3 year: | -38.59% (2.41) |
| Change price per year to date: | +29.82% (1.14) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Artal Group S.A. | 755 | 1.84 |
| BOOTHBAY FUND MANAGEMENT, LLC | 420 | 1.02 |
| Syncona Portfolio Ltd | 11 | 26.98 |
| Fcpm III Services B.v. | 2 | 5.82 |
| Redmile Group, LLC | 2 | 3.91 |
| Vestal Point Capital, LP | 2 | 3.65 |
| Ikarian Capital, LLC | 1 | 3.51 |
| Stempoint Capital LP | 1 | 3.37 |
| Baker Brothers Advisors, LLC | 1 | 2.94 |
| Renaissance Technologies, LLC | 1 | 2.45 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. | Founder | N/A | 1963 (62 years) |
| Dr. Charles Swanton FMEDSCI, M.D., Ph.D. | Founder | N/A | 1972 (53 years) |
| Dr. Sergio A. Quezada Ph.D. | Founder & Chief Scientific Officer | N/A | 1975 (50 years) |
| Mr. Robert Coutts | Chief Financial Officer | N/A | 1984 (41 year) |
| Mr. Lee M. Stern | Vice President of Investor Relations & External Communications | N/A | |
| Julia Wilson | Head of Communications | N/A | |
| Mr. Tariq Ahmed | Executive Vice President of People | N/A | |
| Dr. Karl Stuart Peggs M.D. | Founder & Chief Medical Officer | N/A | 1967 (58 years) |
| Mr. Daniel Carey Cazel Hood | General Counsel & Company Secretary | N/A | |
| Dr. Iraj Ali Ph.D. | CEO & Director | N/A | 1975 (50 years) |
Address: United Kingdom, London W PW, 245 Hammersmith Road - open in Google maps, open in Yandex maps
Website: https://www.achillestx.com
Website: https://www.achillestx.com
